Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Zion Oil and Gas Inc ZNOG

Zion Oil & Gas, Inc. is an oil and gas exploration company. The Company holds replacement license for New Megiddo License 428 (NML 428), which lies onshore, south, and west of the Sea of Galilee. Its wholly owned subsidiaries include Zion Drilling, Inc., which is focused on owning a drilling rig, related equipment and spare parts, and Zion Drilling Services, Inc., which acts as the contractor... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (OTCQB:ZNOG)

No current opinion is available.

Bullboard Posts (OTCQB:ZNOG)

Expected earnings - Zion Oil & Gas Inc

News; $ZNOG Expected earnings - Zion Oil & Gas IncZion Oil @ Gas Inc (ZNOG) is expected to report for Q4 2023ZNOG - Expected...
whytestocks - February 8, 2024

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
Carsten - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

   
Carsten - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
Carsten - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
Carsten - June 2, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
Carsten - May 11, 2022